These results, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 assist the idea of targeting ACKR3 as a singular method to modulate the opioid program, which could open up new therapeutic avenues for opioid-related disorders. Healthier joints let us to https://judyu951umb8.wikitron.com/user